Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study.
Marousa KouvelaMaria Effrosyni LivanouDimitra T StefanouIoannis A VathiotisFotini SarropoulouMaria GrammoustianouEvangelos DimakakosNikolaos K SyrigosPublished in: Cancers (2024)
Thromboprophylaxis with an intermediate Tinzaparin dose in high thrombotic-risk lung cancer patients is a safe and effective choice for the prevention of VTE.